| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000254162.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.009066269 |
Resistant |
| ENSG00000254162.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020451517 |
Resistant |
| ENSG00000254162.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042560934 |
Sensitive |
